BRONCHITIS and Ativan

PatientsVille

BRONCHITIS Symptoms and Causes

Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of Bronchitis: acute and chronic.

Most cases of acute Bronchitis get better within several days. But your cough can last for several weeks after the infection is gone.

The same viruses that cause colds and the flu often cause acute Bronchitis. These viruses spread through the air when people cough, or though physical contact (for example, on unwashed hands). Being exposed to tobacco smoke, air pollution, dusts, vapors, and fumes can also cause acute Bronchitis. Less often, bacteria can also cause acute Bronchitis.

To diagnose acute Bronchitis, your health care provider will ask about your symptoms and listen to your breathing. You may also have other tests.

Treatments include rest, fluids, and aspirin (for adults) or acetaminophen to treat fever. A humidifier or steam can also help. You may need inhaled medicine to open your airways if you are wheezing. Antibiotics won't help if the cause is viral. You may get antibiotics if the cause is bacterial.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for BRONCHITIS

➢ BRONCHITIS treatment research studies

➢ Ativan clinical trials, surveys and public health registries

Find Drug Side Effect reports

Ativan Side Effects

Anxiety (68)

Pain (51)

Insomnia (44)

Depression (42)

Confusional State (41)

Dyspnoea (36)

Nausea (36)

Headache (36)

Somnolence (34)

Fatigue (34)

Asthenia (32)

Feeling Abnormal (30)

Amnesia (30)

Dizziness (29)

Agitation (28)

Diarrhoea (27)

Hallucination (25)

Loss Of Consciousness (23)

Death (23)

Convulsion (22)

Aggression (22)

Fall (21)

Vomiting (21)

Overdose (21)

Tremor (20)

Pneumonia (20)

Condition Aggravated (20)

Hypotension (20)

Pulmonary Embolism (18)

Depressed Level Of Consciousness (17)

Rash (17)

Dehydration (17)

Coma (17)

Decreased Appetite (16)

Abdominal Pain (16)

Malaise (16)

Mental Status Changes (16)

Constipation (15)

Palpitations (14)

Disorientation (14)

Injury (14)

Pyrexia (13)

Nervousness (13)

Tachycardia (13)

Vision Blurred (13)

Emotional Distress (12)

Deep Vein Thrombosis (12)

Pruritus (12)

Urinary Tract Infection (12)

Pain In Extremity (12)

➢ More

Common Meds

Abilify (10132)

Adderall (1304)

Amlodipine (6664)

Amoxicillin (4387)

Benadryl (1568)

Celebrex (12876 )

Celexa (1342)

Cialis (2975)

Cipro (8580)

Citalopram (7792)

Crestor (18839)

Cymbalta (14373)

Doxycycline (1757)

Effexor (7289)

Flexeril (435)

Flomax (2177)

Fluoxetine (4261)

Gabapentin (4593)

Hydrocodone (2469)

Ibuprofen (8222)

Lantus (10968)

Lexapro (3499)

Lipitor (17769)

Lisinopril (8919)

Lyrica (27148)

Medrol (650)

Mirena (41254)

Mobic (957)

Morphine (5356)

Naproxen (538)

Neurontin (6501)

Oxycodone (4438)

Pradaxa (13372)

Prednisone (5926)

Prilosec (2631)

Prozac (1954)

Seroquel (27216)

Simvastatin (8348)

Synthroid (4452)

Tamiflu (5585)

Topamax (3748)

Tramadol (5054)

Trazodone (1458)

Viagra (5394)

Vicodin (1153)

Wellbutrin (6324)

Xanax (2847)

Zocor (5718)

Zoloft(6792)

Zyrtec(1669)

Recent Reviews

i losing weight doctor say i might have bonchitis

Does valium cause afib?

HELLO TO ALL, I was diagnosed with bronchitis 2 weeks ago took a 7 day antibiotic stared feeling a lot better 2weeks after and now i'm sick all over again runny nose congested lungs feel like their boiling inside me coughing up flame but c

Hello, after xray report says normal size cardiac silhouette. bronchitic change seen both lungs. please advice

I am a 20 year old female with bronchitis. A 9mm lung nodule was found on my xray. I have smoked very FEW times. In the past 3 weeks I have lost my voice multiple times, and have a had a pretty bad cough. Other symptoms that could possibly be related

I am a very well managed Astmatic patient. Had a cold, turned into a bout of sinus and now I ahae a sinobronchitis. Infected mucus, low degree of temp esp at night. I am going for a Bunion operation in 10 days. I cannot take augmentin and would like

I hade bacterial prostatit and i used too many antibiotik but not help but when i used alprazolam or ativan sudenly i became okai but problem is i dident find ativan in ukraine and my sister always send to me ativan frome canada some body plea

I have had it up tp 20 timess

I took this for 3 weeks and by the end of my treatment I wanted to shoot everyone in my home, myself included.

I was having bad dreams and anxiety attacks (My Mom was murdered in 2005). I started drinking to calm my nerves, but decided to quit alcohol. I was told by a nurse that quiting 'Cold Turkey' could be dangerous, so I went to see th

i have bronchitis problem, doctor prescribed me zanocin 400mg , i have bowel irritation, little drowsiness

Advair... This was in thesummer of 2004. I had walking pnemonia. Advaid made it worse. I started getting headaches, I couldn't breath and developed bronchitis I coughed all the time. After taking it and for the next four years,I w

After taking the tablets two days, starting seeing blood in urine, by 3rd day, urine was nothing but blood. I was give this for bronchitis

DO NOT TAKE THIS MEDICATION, YOU CAN DIE.... THIS SHOULD BE TAKEN OFF i AM 27 YEARS OLD I TOOK THIS BECAUSE MY DOCTOR SAID I MIGHT BE GETTING BRONCHITIS, 5-10 MINUTES AFTER I TOOK IT, I STARTED SHAKING, I COULDN'T BREATH, I COUNDN'T MOVE, AND I HAD

Has anyone else suffered from Atenelol induced Asthama and Bronchitis?

Hello, I have been diagnosed with bronchitis. Dr. prescribed Azithromycin in 08/21/2010 (250 mg) 6 doses-five days. today is 09/10/2010, and i still experiencing some of the side effects

Hi Every Body, Likewise others, i would also like to share my bad experience withTivanic. I was suffering from Bronchitis, which had prolonged and eventually My physician has to prescribe me Tivanic. 1st 2 days were normal, but then I had

I am a 31 year old female. I weigh 125 lbs. I took Enbrel on and off for about 3 years for chronic psoriasis. Towards the end of my last treatment and since, I have been diagnosed with chronic accute bronchitis, chronic

BRONCHITIS Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.

Rank

Status

Study

Unknown ^†

Acute Effect of Lorazepam on Brain Activity Measured by Magnetoencephalograpy (MEG) and Electroencephalography (EEG)

Condition:	Healthy Subjects
Interventions:	Drug: Lorazepam; Drug: Placebo
Outcome Measures:	Correlated Brain Activity using MEG and SNI analysis; Correlated Brain Activity using MEG and standard analyses

Unknown ^†

Effect of Additive Lorazepam on Patient Satisfaction as a Premedication in Diagnostic Flexible Bronchoscopy

Condition:	Patient Satisfaction for Bronchoscopy
Interventions:	Drug: Lorazepam; Drug: Control
Outcome Measures:	patient satisfaction; relationship between patient satisfaction and sleep quality, anxiety level

Unknown ^†

IM Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia

Conditions:	Schizophrenia; Schizoaffective Disorder; Agitation
Interventions:	Drug: IM olanzapine; Drug: haloperidol plus lorazepam IM
Outcome Measures:	Positive and Negative Symptom Scale Excited Component (PANSS-EC); Agitation-Calmness Evaluation Scale (ACES)

Recruiting

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Condition:	Advanced Cancers
Interventions:	Drug: Lorazepam; Drug: Placebo; Drug: Haloperidol decanoate; Behavioral: Questionnaires
Outcome Measure:	Control of Delirium Symptoms

Recruiting

The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms

Condition:	Alzheimer's Disease (AD)
Intervention:	Drug: lorazepam
Outcome Measures:	AVLT Long term memory score; Groton Maze Learning Test (GMLT) score

Recruiting

Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus

Conditions:	Status Epilepticus; Epilepsy
Interventions:	Drug: Clonazepam; Drug: Fosphenytoin; Drug: Placebo; Drug: Lorazepam
Outcome Measures:	Percentage of patient with a cessation of seizures and absence of recurrence; Duration between the first cessation and the recurrence of seizures; Percentage of patients having had a second injection of benzodiazepine; Percentage of patients having had an injection of the second line treatment; Percentage of patients having a general anesthesia for refractory status epilepticus; Percentage of patients having had a side effect; Percentage of patients having been mechanically ventilated; Glasgow Coma Scale; Mortality; Length of stay in Intensive Care Unit; Length of stay in hospital

Not yet recruiting

Clobazam Use in Epilepsia Partialis Continua - Pilot Study

Conditions:	Epilepsia Partialis Continua; Kojewnikov's Epilepsy; Epilepsy
Interventions:	Drug: Clobazam; Drug: Clonazepam; Drug: Lorazepam
Outcome Measures:	Time (measured in minutes) to onset of seizure freedom; Reduction of seizure frequency/minute; Mental status preservation off sedating anticonvulsants as measured by the MoCA© scale; Ambulatory function as measured by the Hauser Ambulation Index

Recruiting

Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly

Condition:	Healthy Volunteers
Interventions:	Drug: etifoxine; Drug: lorazepam; Drug: Placebo
Outcome Measure:	Reaction time (RTI) of Cambridge Neuropsychological Test Automated Batteries (CANTAB)

Recruiting

Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in Elderly

Condition:	Volunteers Aged Between 65 and 75 Years Old
Interventions:	Drug: etifoxine; Drug: Lorazepam; Drug: Placebo
Outcome Measure:	Reaction time (RTI) of Cambridge Neuropsychological Test Automated Batteries (CANTAB)

Recruiting

Characterizing and Predicting Drug Effects on Cognition

Condition:	Cognitive Deficits
Interventions:	Drug: Topiramate; Drug: Lorazepam
Outcome Measures:	Relationship between neurocognitive performance and study drug plasma concentration; Neurophysiological effect of study drug on working memory

Recruiting

Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (AATD)

Conditions:	Liver Fibrosis; Alpha-1 Antitrypsin Deficiency; AAT Deficiency; AATD
Interventions:	Device: Abdominal ultrasound; Procedure: History and physical; Procedure: Intravenous catheter; Procedure: Blood draw; Other: Liver questionnaire; Procedure: Liver Biopsy; Drug: Midazolam; Drug: Fentanyl; Drug: Lidocaine; Drug: Acetaminophen; Drug: Lorazepam; Drug: Oxycodone/Acetaminophen; Drug: Ondansetron
Outcome Measures:	To estimate the prevalence and histologic spectrum of liver injury in an adult with Alpha-1 Antitrypsin deficiency and a genotype of ZZ.; To identify environmental and host risk factors for clinically significant liver fibrosis.; To define the diagnostic accuracy of non-invasive markers of fibrosis in AAT liver disease.; To explore epigenetic markers for the development of liver fibrosis.; To quantify liver fibrosis progression.

Recruiting

Sedative Premedication: Efficacy On Patient Experience

Condition:	Perioperative Anxiety
Interventions:	Drug: Lorazepam; Other: no premedication; Drug: Placebo (microcrystalline celluloses)
Outcome Measures:	the EVAN score; the perioperative level of anxiety

Not yet recruiting

Explanation About Sleep in Post Trauma Patients

Conditions:	Post Traumatic Stress Disorder; Sleep Deprivation
Interventions:	Behavioral: Explanation encouraging sleep; Behavioral: Explanation discouraging sleep; Drug: Lorazepam
Outcome Measure:	PTSD severity as measured by CAPS

Recruiting

Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability

Condition:	Dental Care for Disabled
Interventions:	Drug: Midazolam Mylan; Drug: Lorazepam Mylan; Drug: Valium + Akineton + Dehydrobenzperidol + Atropine sulfate
Outcome Measures:	Level of cooperation of patient when receiving regular dental care; Recording of vital parameters during regular dental care delivery; Level of patient comfort and possible side-effects after dental treatment session

Recruiting

A First In Human Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Single Oral Doses Of PF-06372865

Condition:	Healthy
Interventions:	Drug: PF-06372865 or Placebo; Drug: PF-06372865 or Placebo or Lorazepam
Outcome Measures:	Maximum Observed Plasma Concentration (Cmax); Area Under the Curve From Time Zero to Last Quantifiable Concentration (AUClast); Area Under the Curve From Time Zero to Extrapolated Infinite Time; Apparent Oral Clearance (CL/F); Apparent Volume of Distribution (Vz/F); Plasma Decay Half-Life (t1/2); Area Under the Curve From Time Zero to 24 hours; Change in Saccadic Eye Movements (saccadic reaction time, saccadic peak velocity and saccadic inaccuracy); Change in Body Sway; Change in Smooth Pursuit; Change in Bond and Lader VAS; Change in Adaptive Tracking; Change in Visual Verbal Learning Test; Change in Pharmaco-EEG

Unknown ^†

Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients

Conditions:	Critical Illness; Mechanical Ventilation Complication
Interventions:	Procedure: Enteral Sedation (EN); Procedure: Control group: Intravenous Sedation (IV)
Outcome Measures:	Percent of efficacy, measured by observed RASS = desired RASS ± 1.; Sedation protocol effectiveness: percentage of "protocol violation days" on the total of ICU days.; Delirium and coma free days (respectively negative CAM-ICU and RASS > - 3 in all daily observations until 28° ICU day) (11); Ventilation free days (12); Nursing evaluation of sedation adequacy (communication skills, cooperation, environment tolerance) (13); Overall ICU and hospital mortality, absolute mortality after 1 year from ICU discharge.; Sedative drugs costs.; Indirect inefficacy markers

Recruiting

Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)

Conditions:	Alcohol Withdrawal Delirium; Alcohol Withdrawal Associated Autonomic Hyperactivity; Alcohol Withdrawal Hallucinosis; Alcohol Withdrawal-Induced Delirium Tremens
Interventions:	Drug: Dexmedetomidine; Drug: Placebo
Outcome Measures:	The length of ICU stay defined as the time between randomization and ICU transfer orders.; The number of delirium-free and ventilator-free days during the first 28 days of hospitalization; The length in days of the hospital stay; Scores at hospital discharge on the Mini Mental Exam, Beck Depression Inventory, Beck Anxiety Inventory and PTSD checklist.; Resource utilization costs associated with this hospitalization.; Predefined adverse events; average MINDS score

Unknown ^†

Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression

Condition:	Depression
Interventions:	Device: Thrymatron System IV device (CONSOLIDATION ELECTROCONVUsLIVE THERAPY) plus PHARMACOTHERAPY; Drug: PHARMACOTHERAPY
Outcome Measures:	Hamilton Depression Rating Scale 21 items (HDRS-21); Mini-Mental State Examination (MMSE 35); UKU - Adverse effects rating scales; Demographical Data Memory (MEDABI-20); Rey Figure; Trail Making Test A; Trail Making Test B; Stroop Test; Direct and inverse digits (WAIS, Weschler Adults Intelligence Sacle).; Vocabulary WAIS (Weschler Adults Intelligence Scale); Frequency Hospitalization Quotient; Hospital Day Quotient (HDQ)

Not yet recruiting

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Condition:	Lymphoma, Non-Hodgkin
Intervention:	Drug: Standard anti-emetics in conjunction with R-CHOP
Outcome Measures:	Complete Response, Acute Phase (Day 1), Cycle 1; Complete Response, Delayed Phase (Days 2 to 11), Cycle 1; Complete Response - Cycle 2 and beyond; No Significant Nausea - Cycle 2 and beyond; Failure of standard anti-emetic prophylaxis, Day 1 to Day 11, Cycle 1 and beyond; Frequency of common adverse events associated with anti-emetics; Severity of common adverse events associated with anti-emetics

Recruiting

TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation

Conditions:	Cardiac Arrest; Postanoxic Encephalopathy; Status Epilepticus
Interventions:	Drug: Anti-epileptic drugs; Other: No anti-epileptic drugs
Outcome Measures:	Neurological outcome; Long term outcome